|
Skeletal Targeted Radiotherapy (STR™) is designed to be used in combination with high-dose chemotherapy producing a direct therapeutic effect on the tumor sites in the bone plus a general bone-marrow effect to destroy myeloma cells in the bone marrow. It is an experimental therapy that is being developed by NeoRx Corporation.The scientific name of the drug is 166Ho-DOTMP.
|
